^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OvaCis®

    Company:
    INEX Innovate
    Type:
    CE Marked
    Related tests:
    Details
    Evidence

    News

    1year
    INEX Innovate delighted to announce the appointment of Biomed Global as distributor for the launch of OvaCis® - The Company’s Test for Ovarian Cancer in Indonesia, Malaysia, Philippines, Singapore and Thailand. (INEX Innovate Press Release)
    "INEX Innovate is delighted to announce the appointment of Biomed Global as distributor for the launch of OvaCis® - The Company’s Test for Ovarian Cancer in Indonesia, Malaysia, Philippines, Singapore and Thailand."
    Licensing / partnership • Launch non-US
    |
    OvaCis®
    almost2years
    Singapore-based Inex Innovate receives CE Mark for rapid ovarian cancer test (Precision Medicine Online)
    "Inex Innovate...announced on Wednesday that its ovarian cancer test has received CE marking...The point-of-care OvaCis Rapid Test determines whether an ovarian cyst is benign or malignant by measuring haptoglobin, a protein biomarker that is evenly distributed in ovarian cyst fluid. It requires minimal training and five minutes of hands-on time and returns results in 15 minutes."
    European regulatory
    |
    OvaCis®